Venus Remedies Eases Share Transfers with Special Window for Certificate Holders

In Line with SEBI’s Latest Circular, the Pharma Company Offers Shareholders a Chance to Re-lodge Physical Share Transfers


Re-lodgement Window Announced by Venus Remedies

  • Venus Remedies, a leading Indian pharmaceutical company, has opened a special window for re-lodgement of physical share transfer requests.
  • The announcement follows the directives in SEBI Circular No. SEBI/HO/MIRSD/MIRSD-POD/P/CIR/2023/87, dated July 2, 2023.
  • This initiative enables shareholders holding physical share certificates to resubmit pending transfer requests, a step toward facilitating digital dematerialisation and smoother ownership transitions.

Broad Communication via Social Media

  • The company disseminated this update widely across its official social media platforms, including LinkedIn, X (formerly Twitter), Facebook, and Instagram.
  • Links to the official notice and detailed instructions were also shared, ensuring maximum visibility and easy access for shareholders.

Regulatory Alignment and Transparency

  • Venus Remedies confirmed in a stock exchange filing that the move complies with Regulation 30 of the SEBI (LODR) Regulations, 2015.
  • This reinforces the company’s focus on regulatory compliance and its proactive approach to embracing recent SEBI mandates on share transfers.

What This Means for Shareholders

  • Eligible shareholders who hold physical share certificates now have an official channel to re-lodge transfer requests that may have previously been rejected or left incomplete.
  • The process could lead to faster conversion to dematerialised shares or correct ownership records, making future transactions easier and compliant with electronic trading norms.

How to Proceed

  • Interested shareholders can visit the company’s social media pages or refer to the exchange filing for step-by-step instructions.
  • The special window is a time-sensitive opportunity, so shareholders are encouraged to act promptly to resolve any pending physical share issues.

Company Snapshot

  • Venus Remedies is listed on both the National Stock Exchange (NSE) and BSE Limited, making its shares accessible to a wide base of investors.
  • The move reflects the company’s ongoing commitment to transparency, investor service, and staying aligned with evolving SEBI regulations.
Share this article
Shareable URL
Prev Post

Jensen Huang’s Taiwan Visit: More Than Just Thanks to TSMC

Next Post

Vodafone Idea’s Survival Struggle Deepens in Duopoly-Dominated Market

Read next
0
Share